comparemela.com

South Texas Research Institute News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Texas A&M-McAllen Students Lead Mental Health-Focused Events In Rio Grande Valley Colonias

Public Health students at the Higher Education Center at McAllen hosted a mental health awareness fair and community cleanup.

United statesLesly mataKrystal flores chavezDenise martinezAlamo community resource centerTexas health systems clinicsMental health awareness fairTexas health systems behavioralPublic healthTexasam colonias programTexasam university colonias programTexas research instituteFamily health centerColonias programManagement in public healthImpact teaching grant

Students from Texas A&M s McAllen Higher Education Center assist colonia residents – Rio Grande Guardian

Mental health awareness fair to be held Saturday. April 13, at the Alamo Community Resource Center in Little Mexico.

United statesHidalgo countyKrystal flores chavezAdela arellanoDavid fuentesTexas health systems clinicsTexas health systems behavioralHigher education center at mcallenMcallen higher education centerTexasam higher education centerAltacair foundationFamily health centerManagement in public healthTexasam colonias programRio grande valley partnership in weslacoTexas research institute

NeuroBo Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update

DA-1726 Phase 1 IND Filing Expected by Year End 2023 Board Strengthened with Recent Appointment of Industry Veteran, James P. Tursi, M.D. Cash and Cash Equivalents of $25.8 Million, Expected to Fund.

United statesMarshall woodworthMichael millerZeid kayaliJamesp tursiDavid ramirezFund the company into fourth quarterNeurobo pharmaceuticalsDrug administrationEmpire liver foundationBoard nominating committeeDevelopment rd expensesMthera pharma co ltdNeurobo pharmaceuticals incRx communications groupDonga st co

NeuroBo Pharmaceuticals Doses First Patient in Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of NASH

/PRNewswire/ NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company on a quest to transform cardiometabolic diseases, today.

United statesMichael millerDavid ramirezPrnewswire neurobo pharmaceuticals incRx communications groupNeurobo pharmaceuticalsDonga st coNeurobo pharmaceuticals incTwo part design provides optionalityInterim analysisFirst halfData readout expectedSecond halfG protein coupled receptorSouth texas research institutePrincipal investigator

LongueVue Capital — Mergers & Acquisitions

Mergers & Acquisitions — LongueVue Capital

United statesTexas research instituteSouth texas research institute

vimarsana © 2020. All Rights Reserved.